Unichem Lab gets USFDA nod for Zonisamide Capsules

Unichem Lab gets USFDA nod for Zonisamide Capsules

by admin- Wednesday, January 27th, 2021 03:52:51 PM

Unichem Laboratories received ANDA approval for its Zonisamide Capsules, USP 25 mg, 50 mg and a hundred mg from the US Food and Drug Administration (USFDA) to market a typical model of Zonegran (Zonisamide) Capsules of Sunovion Pharmaceuticals Inc.

Zonisamide Capsules are indicated as adjunctive therapy inside the treatment of partial seizures in adults with epilepsy. The product could be commercialized from Unichem’s Goa Plant.

News Updates